Professor Hai-Fang Yin
Tianjin Medical University
Our group focuses on development of novel drug delivery systems including tissue-targeting peptide, natural compounds and exosomes and their applications in Duchenne Muscular Dystrophy (DMD) and hepatocellular carcinoma (HCC) with recent publications in Science Translational Medicine, Nature Communications, Hepatology and Journal of Hepatology et al.